Metraipolis › archive › dc_a4dee9117213

Targeting metabolic vulnerabilities in breast cancer cells by combining PEDF and doxorubicin: pathway insights from GC/MS-based metabolomics — Europe PMC PMID:40964171

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40964171
DOI
10.17179/excli2025-8508
License (as archived)
solo-consultazione
Archived
2026-11-10T12:39:52.220Z
SHA-256 of the archived text
8ecfcea5e31693d9ba5f617572dc66f679af42b901dd2cda645dd2a3ae817b31
Stable URL of this page
https://metraipolis.com/documento/dc_a4dee9117213

How to cite

Targeting metabolic vulnerabilities in breast cancer cells by combining PEDF and doxorubicin: pathway insights from GC/MS-based metabolomics — Europe PMC PMID:40964171 — Europe PMC (en), https://europepmc.org/article/MED/40964171 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a4dee9117213 (Metraipolis archive dc_a4dee9117213, sha256 8ecfcea5e31693d9ba5f617572dc66f679af42b901dd2cda645dd2a3ae817b31)
BibTeX
@misc{dca4dee9117213,
  title = {Targeting metabolic vulnerabilities in breast cancer cells by combining PEDF and doxorubicin: pathway insights from GC/MS-based metabolomics — Europe PMC PMID:40964171},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40964171},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a4dee9117213; sha256 8ecfcea5e31693d9ba5f617572dc66f679af42b901dd2cda645dd2a3ae817b31},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40964171. Agents can read the archived copy with the MCP tool read_document.